The Role of MLH1, MSH2 and MSH6 in the Development of Multiple Colorectal Cancers

Overview

Journal Br J Cancer

Specialty Oncology

Date 2005 Aug 18

PMID 16106253

Citations 28

Authors

D A Lawes

T Pearson

S Sengupta

P B Boulos

Affiliations

Soon will be listed here.

Abstract

There is increased incidence of microsatellite instability (MSI) in patients who develop multiple primary colorectal cancers (CRC), although the association with hereditary nonpolyposis colon cancer (HNPCC) is unclear. This study aims to evaluate the underlying genetic cause of MSI in these patients. Microsatellite instability was investigated in 111 paraffin-embedded CRCs obtained from 78 patients with metachronous and synchronous cancers, and a control group consisting of 74 cancers from patients with a single CRC. Tumours were classified as high level (MSI-H), low level (MSI-L) or stable (MSS). MLH1, MSH2 and MSH6 gene expression was measured by immunohistochemistry. Methylation of the MLH1 promoter region was evaluated in MSI-H cancers that failed to express MLH1, and mutational analysis performed in MSI-H samples that expressed MLH1, MSH2 and MSH6 proteins. The frequency of MSI-H was significantly greater in the multiple, 58 out of 111 (52%), compared to the single cancers, 10 out of 74 (13.5%), P < 0.01. Of the 32 patients from whom two or more cancers were analysed, eight (25%) demonstrated MSI-H in both cancers, 13 (41%) demonstrated MSI-H in one cancer and 11 (34%) failed to demonstrate any MSI-H. MSI-H single cancers failed to express MLH1 or MSH2 in seven out of nine (78%) cases and MSI-L/MSS cancers failed to express MLH1 or MSH2 in one out of 45 (2.2%) cases, all cancers expressed MSH6. MSI-H multiple cancers failed to express MLH1 or MSH2 in 21 out of 43 (48%) cases and MSI-L/MSS cancers failed to express MLH1 or MSH2 in four out of 32 (12.5%) cases. MSH6 expression was lost in five MSI-H multiple cancers, four of which also failed to express MLH1 or MSH2. Loss of expression of the same mismatch repair (MMR) gene was identified in both cancers from six out of 19 (31%) patients. Methylation was identified in 11 out of 17 (65%) multiple and three out of six (50%) single MSI-H cancers that failed to express MLH1. Mutational analysis of 10 MSI-H multiple cancers that expressed MLH1, MSH2 and MSH6 failed to demonstrate mutations in the MLH1 or MSH2 genes. We suggest that, although MSI-H is more commonly identified in those with multiple colorectal cancers, this does not commonly arise from a classical HNPCC pathway.

Citing Articles

Prime Editing and DNA Repair System: Balancing Efficiency with Safety.

Daliri K, Hescheler J, Pfannkuche K Cells. 2024; 13(10.

PMID: 38786078 PMC: 11120019. DOI: 10.3390/cells13100858.

New gold(III) complexes TGS 121, 404, and 702 show anti-tumor activity in colitis-induced colorectal cancer: an in vitro and in vivo study.

Wlodarczyk J, Krajewska J, Talar M, Szeleszczuk L, Gurba A, Lipiec S Pharmacol Rep. 2023; 76(1):127-139.

PMID: 38082190 PMC: 10830623. DOI: 10.1007/s43440-023-00558-1.

Oncologic relevance of genetic alterations in sporadic synchronous and solitary colorectal cancer: a retrospective multicenter study.

Son I, Kim M, Oh B, Kim M, Yoon S, Park J BMC Gastroenterol. 2023; 23(1):297.

PMID: 37667167 PMC: 10478293. DOI: 10.1186/s12876-023-02937-7.

MLH1 Exon 12 Gene Deletion Leading to Lynch Syndrome: A Case Report.

Cui S, Zhang X, Zou R, Ye F, Wang Y, Sun J Oncol Res Treat. 2021; 44(7-8):414-421.

PMID: 34091457 PMC: 8495764. DOI: 10.1159/000516659.

A clinico-pathological and molecular analysis reveals differences between solitary (early and late-onset) and synchronous rectal cancer.

Perea J, Garcia J, Corchete L, Tapial S, Olmedillas-Lopez S, Vivas A Sci Rep. 2021; 11(1):2202.

PMID: 33500439 PMC: 7838158. DOI: 10.1038/s41598-020-79118-z.

References

Lindor N, Burgart L, Leontovich O, Goldberg R, Cunningham J, Sargent D . Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002; 20(4):1043-8. DOI: 10.1200/JCO.2002.20.4.1043. View

Potocnik U, Glavac D, Golouh R, Ravnik-Glavac M . Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening. Cancer Genet Cytogenet. 2001; 126(2):85-96. DOI: 10.1016/s0165-4608(00)00399-x. View

Thompson E, Meldrum C, Crooks R, McPhillips M, Thomas L, Spigelman A . Hereditary non-polyposis colorectal cancer and the role of hPMS2 and hEXO1 mutations. Clin Genet. 2004; 65(3):215-25. DOI: 10.1111/j.1399-0004.2004.00214.x. View

de Jong A, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems M . Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res. 2004; 10(3):972-80. DOI: 10.1158/1078-0432.ccr-0956-3. View

Grompe M . The rapid detection of unknown mutations in nucleic acids. Nat Genet. 1993; 5(2):111-7. DOI: 10.1038/ng1093-111. View

Horii A, Han H, Shimada M, Yanagisawa A, Kato Y, Ohta H . Frequent replication errors at microsatellite loci in tumors of patients with multiple primary cancers. Cancer Res. 1994; 54(13):3373-5. View

Kolodner R, Hall N, Lipford J, Kane M, Rao M, Morrison P . Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics. 1994; 24(3):516-26. DOI: 10.1006/geno.1994.1661. View

Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J . Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science. 1995; 268(5215):1336-8. DOI: 10.1126/science.7761852. View

Aarnio M, Mecklin J, Aaltonen L, Nystrom-Lahti M, Jarvinen H . Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995; 64(6):430-3. DOI: 10.1002/ijc.2910640613. View

10.

Giardiello F, Brensinger J, Petersen G . AGA technical review on hereditary colorectal cancer and genetic testing. Gastroenterology. 2001; 121(1):198-213. DOI: 10.1053/gast.2001.25581. View

11.

Percesepe A, Borghi F, Menigatti M, Losi L, Foroni M, Di Gregorio C . Molecular screening for hereditary nonpolyposis colorectal cancer: a prospective, population-based study. J Clin Oncol. 2001; 19(19):3944-50. DOI: 10.1200/JCO.2001.19.19.3944. View

12.

Samowitz W, Curtin K, Lin H, ROBERTSON M, Schaffer D, Nichols M . The colon cancer burden of genetically defined hereditary nonpolyposis colon cancer. Gastroenterology. 2001; 121(4):830-8. DOI: 10.1053/gast.2001.27996. View

13.

Yamamoto H, Min Y, Itoh F, Imsumran A, Horiuchi S, Yoshida M . Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability. Genes Chromosomes Cancer. 2002; 33(3):322-5. DOI: 10.1002/gcc.10010. View

14.

Wijnen J, Khan P, Vasen H, Menko F, van der Klift H, van den Broek M . Majority of hMLH1 mutations responsible for hereditary nonpolyposis colorectal cancer cluster at the exonic region 15-16. Am J Hum Genet. 1996; 58(2):300-7. PMC: 1914526. View

15.

Liu B, Parsons R, Papadopoulos N, Nicolaides N, Lynch H, Watson P . Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996; 2(2):169-74. DOI: 10.1038/nm0296-169. View

16.

Lynch H . Is there a role for prophylactic subtotal colectomy among hereditary nonpolyposis colorectal cancer germline mutation carriers?. Dis Colon Rectum. 1996; 39(1):109-10. DOI: 10.1007/BF02048279. View

17.

Souza R, Appel R, Yin J, Wang S, Smolinski K, Abraham J . Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet. 1996; 14(3):255-7. DOI: 10.1038/ng1196-255. View

18.

Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed J . Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 1997; 275(5302):967-9. DOI: 10.1126/science.275.5302.967. View

19.

Beck N, Tomlinson I, Homfray T, Hodgson S, Harocopos C, Bodmer W . Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997; 84(2):233-7. View

20.

Souza R, Yin J, Smolinski K, Zou T, Wang S, Shi Y . Frequent mutation of the E2F-4 cell cycle gene in primary human gastrointestinal tumors. Cancer Res. 1997; 57(12):2350-3. View